375 related articles for article (PubMed ID: 26474495)
1. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
Chintala SK
Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms regulating plasminogen activators in transformed retinal ganglion cells.
Rock N; Chintala SK
Exp Eye Res; 2008 Mar; 86(3):492-9. PubMed ID: 18243176
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of plasminogen activators attenuates the death of differentiated retinal ganglion cells and stabilizes their neurite network in vitro.
Harvey R; Chintala SK
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1884-91. PubMed ID: 17389524
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells.
Ganesh BS; Chintala SK
PLoS One; 2011 Mar; 6(3):e18305. PubMed ID: 21483783
[TBL] [Abstract][Full Text] [Related]
6. Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.
Matsumoto Y; Kanamori A; Nakamura M; Negi A
Jpn J Ophthalmol; 2014 May; 58(3):290-7. PubMed ID: 24610540
[TBL] [Abstract][Full Text] [Related]
7. Norrin attenuates protease-mediated death of transformed retinal ganglion cells.
Lin S; Cheng M; Dailey W; Drenser K; Chintala S
Mol Vis; 2009; 15():26-37. PubMed ID: 19137075
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activators promote excitotoxicity-induced retinal damage.
Mali RS; Cheng M; Chintala SK
FASEB J; 2005 Aug; 19(10):1280-9. PubMed ID: 16051695
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
10. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.
Chen H; Wei X; Cho KS; Chen G; Sappington R; Calkins DJ; Chen DF
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):36-44. PubMed ID: 20702815
[TBL] [Abstract][Full Text] [Related]
11. Prolonged elevation of intraocular pressure results in retinal ganglion cell loss and abnormal retinal function in mice.
Khan AK; Tse DY; van der Heijden ME; Shah P; Nusbaum DM; Yang Z; Wu SM; Frankfort BJ
Exp Eye Res; 2015 Jan; 130():29-37. PubMed ID: 25450059
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of ocular hypertension with retinal ganglion cell degeneration.
Mukai R; Park DH; Okunuki Y; Hasegawa E; Klokman G; Kim CB; Krishnan A; Gregory-Ksander M; Husain D; Miller JW; Connor KM
PLoS One; 2019; 14(1):e0208713. PubMed ID: 30640920
[TBL] [Abstract][Full Text] [Related]
13. Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma.
Frankfort BJ; Khan AK; Tse DY; Chung I; Pang JJ; Yang Z; Gross RL; Wu SM
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):762-70. PubMed ID: 23221072
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
15. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
17. Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.
Chintala SK; Putris N; Geno M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(1):505-14. PubMed ID: 25564448
[TBL] [Abstract][Full Text] [Related]
18. Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.
Wareham LK; Dordea AC; Schleifer G; Yao V; Batten A; Fei F; Mertz J; Gregory-Ksander M; Pasquale LR; Buys ES; Sappington RM
Neurobiol Dis; 2019 Jan; 121():65-75. PubMed ID: 30213732
[TBL] [Abstract][Full Text] [Related]
19. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
Jögi A; Rønø B; Lund IK; Nielsen BS; Ploug M; Høyer-Hansen G; Rømer J; Lund LR
PLoS One; 2010 Sep; 5(9):e12746. PubMed ID: 20856796
[TBL] [Abstract][Full Text] [Related]
20. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
